Literature DB >> 10768085

Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock.

R A Balk1.   

Abstract

Organ system dysfunction is a common adverse sequelae of severe sepsis and septic shock and has been reported to be the most common cause of death in the noncoronary intensive care unit. The pathophysiology of the development of multiple organ system dysfunction is likely multifactoral and may take several different pathways. The frequency of specific organ system involvement is dependent on the definition used to describe the organ dysfunction. The presence of organ dysfunction has great clinical impact on the underlying disease process, can prolong the hospital stay, increase the cost of care, and has been associated with an increase in mortality rate. At present, there is no recognized specific treatment for established organ failure, this primary attention has been directed toward prevention.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10768085     DOI: 10.1016/s0749-0704(05)70113-5

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  26 in total

1.  Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.

Authors:  Vesna Degoricija; Mirella Sharma; Ante Legac; Marina Gradiser; Sinisa Sefer; Zeljko Vucicević
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

2.  Direct hemoperfusion with a cytokine-adsorbing device for the treatment of persistent or severe hypercytokinemia: a pilot study.

Authors:  Y Kobe; S Oda; K Matsuda; M Nakamura; H Hirasawa
Journal:  Blood Purif       Date:  2007-11-23       Impact factor: 2.614

Review 3.  A brief overview of acute respiratory distress syndrome.

Authors:  Robert M Hardaway
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

4.  Impact of early enteral nutrition on in-hospital mortality in patients with hypertensive intracerebral hemorrhage.

Authors:  Jeong-Shik Lee; Cheol-Su Jwa; Hyeong-Joong Yi; Hyoung-Joon Chun
Journal:  J Korean Neurosurg Soc       Date:  2010-08-31

5.  The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells.

Authors:  Joo Sung Kim; Christian Jobin
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

6.  Phosphorylation of extracellular signal-regulated kinase (ERK)-1/2 Is associated with the downregulation of peroxisome proliferator-activated receptor (PPAR)-γ during polymicrobial sepsis.

Authors:  Jennifer M Kaplan; Paul W Hake; Alvin Denenberg; Marchele Nowell; Giovanna Piraino; Basilia Zingarelli
Journal:  Mol Med       Date:  2010-08-19       Impact factor: 6.354

7.  G-protein coupled receptor kinase 5 mediates lipopolysaccharide-induced NFκB activation in primary macrophages and modulates inflammation in vivo in mice.

Authors:  Sonika Patial; Shipra Shahi; Yogesh Saini; Taehyung Lee; Nandakumar Packiriswamy; Daniel M Appledorn; John J Lapres; Andrea Amalfitano; Narayanan Parameswaran
Journal:  J Cell Physiol       Date:  2011-05       Impact factor: 6.384

8.  Commensal microflora induce host defense and decrease bacterial translocation in burn mice through toll-like receptor 4.

Authors:  Lee-Wei Chen; Wei-Jung Chang; Pei-Hsuan Chen; Ching-Mei Hsu
Journal:  J Biomed Sci       Date:  2010-06-12       Impact factor: 8.410

9.  An evaluation of the cost effectiveness of drotrecogin alfa (activated) relative to the number of organ system failures.

Authors:  Madeline Betancourt; Peggy S McKinnon; R Michael Massanari; Salmaan Kanji; David Bach; John W Devlin
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections.

Authors:  A Lekkou; M Karakantza; A Mouzaki; F Kalfarentzos; C A Gogos
Journal:  Clin Diagn Lab Immunol       Date:  2004-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.